Skip to main content


Bakker, A. B., W. E. Marissen, et al. (2005). "Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants." Journal of Virology 79(14): 9062-9068.

Benmansour, A., H. Leblois, et al. (1991). "Antigenicity of rabies virus glycoprotein." Journal of Virology 65(8): 4198-4203.

Dietzschold, B., C. E. Rupprecht, et al. (1988). "Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies." Reviews of Infectious Diseases 10 Suppl 4: S785-798.

Dietzschold, B., T. J. Wiktor, et al. (1983). "Chemical and immunological analysis of the rabies soluble glycoprotein." Virology 124(2): 330-337.

Hanlon, C. A., I. V. Kuzmin, et al. (2005). "Efficacy of rabies biologics against new lyssaviruses from Eurasia." Virus Research 111(1): 44-54.

Lafon, M., L. Edelman, et al. (1990). "Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein." Journal of General Virology 71 ( Pt 8): 1689-1696.

Mebatsion, T., M. J. Schnell, et al. (1995). "Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles." Journal of Virology 69(3): 1444-1451.

Walker, P. J. and K. Kongsuwan (1999). "Deduced structural model for animal rhabdovirus glycoproteins." Journal of General Virology 80 ( Pt 5): 1211-1220.


Wright, E., N. J. Temperton, D. A. Marston, L. M. McElhinney, A. R. Fooks and R. A. Weiss (2008). "Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison." Journal of General Virology 89(Pt 9): 2204-2213.


Wright, E., S. McNabb, T. Goddard, D. L. Horton, T. Lembo, L. H. Nel, R. A. Weiss, S. Cleaveland and A. R. Fooks (2009). "A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa." Vaccine 27(51): 7178-7186.


Useful Links